Spontaneous giant chest wall hematomas in COVID-19 patients: case report

Shanghai chest Pub Date : 2022-04-01 DOI:10.21037/shc-21-29
Á. Fuentes-Martín, Ángel Cilleruelo Ramos, J. Soro-García, José María Matilla González
{"title":"Spontaneous giant chest wall hematomas in COVID-19 patients: case report","authors":"Á. Fuentes-Martín, Ángel Cilleruelo Ramos, J. Soro-García, José María Matilla González","doi":"10.21037/shc-21-29","DOIUrl":null,"url":null,"abstract":"Background: Spontaneous chest wall hematomas are an extremely rare clinical finding. Bleeding manifestations without other associated factors have not yet been re-ported in COVID-19 disease. Case Description: We report the cases of two patients with severe COVID-19 disease who debuted with a giant spontaneous chest wall hematoma at our institution without a history of traumatic event or previous invasive procedure. Both patients, a 75-year-old male and a 96-year-old woman, were in a resolution stage of their COVID-19 bilateral pneumonia and were receiving prophylactic dose low-molecular-weight heparin. The initial symptoms in both patients were the appearance of chest pain with a rapidly progressive indurated mass in the pectoral region. The imaging test of choice were computed chest tomography and an angiographic study, which allowed the identification of the possible origin of the bleeding and its subsequent selective embolization. Surgical drainage of the hematoma was necessary in one of the patients. Both patients presented a good clinical evolution, being able to be discharged from the hospital approximately one week after admission, with hematoma in the resolution phase and without clinical, laboratory or radiological data of active bleeding. Conclusions: We consider it necessary to individualize antithrombotic prophylaxis in COVID-19 disease until the risk-benefit ratio is delimited. © 2022 by Prusa Medical Publishing.","PeriodicalId":74794,"journal":{"name":"Shanghai chest","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shanghai chest","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/shc-21-29","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Spontaneous chest wall hematomas are an extremely rare clinical finding. Bleeding manifestations without other associated factors have not yet been re-ported in COVID-19 disease. Case Description: We report the cases of two patients with severe COVID-19 disease who debuted with a giant spontaneous chest wall hematoma at our institution without a history of traumatic event or previous invasive procedure. Both patients, a 75-year-old male and a 96-year-old woman, were in a resolution stage of their COVID-19 bilateral pneumonia and were receiving prophylactic dose low-molecular-weight heparin. The initial symptoms in both patients were the appearance of chest pain with a rapidly progressive indurated mass in the pectoral region. The imaging test of choice were computed chest tomography and an angiographic study, which allowed the identification of the possible origin of the bleeding and its subsequent selective embolization. Surgical drainage of the hematoma was necessary in one of the patients. Both patients presented a good clinical evolution, being able to be discharged from the hospital approximately one week after admission, with hematoma in the resolution phase and without clinical, laboratory or radiological data of active bleeding. Conclusions: We consider it necessary to individualize antithrombotic prophylaxis in COVID-19 disease until the risk-benefit ratio is delimited. © 2022 by Prusa Medical Publishing.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19患者自发性巨大胸壁血肿1例
背景:自发性胸壁血肿是一种极为罕见的临床表现。无其他相关因素的出血表现在COVID-19疾病中尚未报道。病例描述:我们报告了两例重症COVID-19患者,他们在我院首次出现巨大的自发性胸壁血肿,没有创伤事件史或先前的侵入性手术。两名患者,一名75岁男性和一名96岁女性,均处于COVID-19双侧肺炎的缓解阶段,并正在接受预防性剂量低分子肝素治疗。两例患者的初始症状均为胸痛并伴胸区迅速进展的硬化肿块。选择的影像学检查是胸部计算机断层扫描和血管造影研究,这可以确定出血的可能来源和随后的选择性栓塞。其中1例患者需要手术引流血肿。两例患者均表现出良好的临床进展,入院后约一周即可出院,血肿处于消退期,无活动性出血的临床、实验室或放射学资料。结论:我们认为在确定风险-收益比之前,有必要对COVID-19疾病进行个体化抗血栓预防。©2022 by Prusa Medical Publishing。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.70
自引率
0.00%
发文量
0
期刊最新文献
Learning curves for minimally invasive major lung resections: facts and action points! Comparative efficacy of lobar resection and sublobar resection in patients with stage IA lung invasive mucinous adenocarcinoma: insights from the SEER database with propensity score matching First clinical application of a surgical robot with haptic force feedback function for thoracic surgery: a case report A cautionary tale for thoracic surgery teams: unexpected surgical fire during open-window thoracostomy: a case report Giant thymolipoma in a patient with severe COVID-19 pneumonia: case report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1